OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Tissue-resident memory and circulating T cells are early responders to pre-surgical cancer immunotherapy
Adrienne Luoma, Shengbao Suo, Yifan Wang, et al.
Cell (2022) Vol. 185, Iss. 16, pp. 2918-2935.e29
Open Access | Times Cited: 235
Adrienne Luoma, Shengbao Suo, Yifan Wang, et al.
Cell (2022) Vol. 185, Iss. 16, pp. 2918-2935.e29
Open Access | Times Cited: 235
Showing 1-25 of 235 citing articles:
Dynamics and specificities of T cells in cancer immunotherapy
Giacomo Oliveira, Catherine J. Wu
Nature reviews. Cancer (2023) Vol. 23, Iss. 5, pp. 295-316
Closed Access | Times Cited: 240
Giacomo Oliveira, Catherine J. Wu
Nature reviews. Cancer (2023) Vol. 23, Iss. 5, pp. 295-316
Closed Access | Times Cited: 240
Dynamic CD8+ T cell responses to cancer immunotherapy in human regional lymph nodes are disrupted in metastatic lymph nodes
Maha K. Rahim, Trine Line Hauge Okholm, Kyle B. Jones, et al.
Cell (2023) Vol. 186, Iss. 6, pp. 1127-1143.e18
Open Access | Times Cited: 212
Maha K. Rahim, Trine Line Hauge Okholm, Kyle B. Jones, et al.
Cell (2023) Vol. 186, Iss. 6, pp. 1127-1143.e18
Open Access | Times Cited: 212
A pan-cancer single-cell panorama of human natural killer cells
Fei Tang, Jinhu Li, Lu Qi, et al.
Cell (2023) Vol. 186, Iss. 19, pp. 4235-4251.e20
Open Access | Times Cited: 161
Fei Tang, Jinhu Li, Lu Qi, et al.
Cell (2023) Vol. 186, Iss. 19, pp. 4235-4251.e20
Open Access | Times Cited: 161
Impact of the Human Cell Atlas on medicine
Jennifer Rood, Aidan Maartens, Anna Hupalowska, et al.
Nature Medicine (2022) Vol. 28, Iss. 12, pp. 2486-2496
Open Access | Times Cited: 145
Jennifer Rood, Aidan Maartens, Anna Hupalowska, et al.
Nature Medicine (2022) Vol. 28, Iss. 12, pp. 2486-2496
Open Access | Times Cited: 145
Neoadjuvant immune checkpoint blockade: A window of opportunity to advance cancer immunotherapy
Suzanne L. Topalian, Patrick M. Forde, Leisha A. Emens, et al.
Cancer Cell (2023) Vol. 41, Iss. 9, pp. 1551-1566
Open Access | Times Cited: 131
Suzanne L. Topalian, Patrick M. Forde, Leisha A. Emens, et al.
Cancer Cell (2023) Vol. 41, Iss. 9, pp. 1551-1566
Open Access | Times Cited: 131
Intratumoral CD8+ T cells with a tissue-resident memory phenotype mediate local immunity and immune checkpoint responses in breast cancer
Balaji Virassamy, Franco Caramia, Peter Savas, et al.
Cancer Cell (2023) Vol. 41, Iss. 3, pp. 585-601.e8
Open Access | Times Cited: 107
Balaji Virassamy, Franco Caramia, Peter Savas, et al.
Cancer Cell (2023) Vol. 41, Iss. 3, pp. 585-601.e8
Open Access | Times Cited: 107
Clinical trial links oncolytic immunoactivation to survival in glioblastoma
Alexander Ling, Isaac H. Solomon, Ana Montalvo Landivar, et al.
Nature (2023) Vol. 623, Iss. 7985, pp. 157-166
Open Access | Times Cited: 105
Alexander Ling, Isaac H. Solomon, Ana Montalvo Landivar, et al.
Nature (2023) Vol. 623, Iss. 7985, pp. 157-166
Open Access | Times Cited: 105
Stem-like exhausted and memory CD8+ T cells in cancer
Thomas Gebhardt, Simone L. Park, Ian A. Parish
Nature reviews. Cancer (2023) Vol. 23, Iss. 11, pp. 780-798
Closed Access | Times Cited: 73
Thomas Gebhardt, Simone L. Park, Ian A. Parish
Nature reviews. Cancer (2023) Vol. 23, Iss. 11, pp. 780-798
Closed Access | Times Cited: 73
Immunosuppression for immune-related adverse events during checkpoint inhibition: an intricate balance
Rik J. Verheijden, Mick J M van Eijs, Anne M. May, et al.
npj Precision Oncology (2023) Vol. 7, Iss. 1
Open Access | Times Cited: 53
Rik J. Verheijden, Mick J M van Eijs, Anne M. May, et al.
npj Precision Oncology (2023) Vol. 7, Iss. 1
Open Access | Times Cited: 53
Towards targeting the breast cancer immune microenvironment
Michael A. Harris, Peter Savas, Balaji Virassamy, et al.
Nature reviews. Cancer (2024) Vol. 24, Iss. 8, pp. 554-577
Closed Access | Times Cited: 53
Michael A. Harris, Peter Savas, Balaji Virassamy, et al.
Nature reviews. Cancer (2024) Vol. 24, Iss. 8, pp. 554-577
Closed Access | Times Cited: 53
Multiomics and spatial mapping characterizes human CD8 + T cell states in cancer
Stefan Naulaerts, Angeliki Datsi, Daniel Borràs, et al.
Science Translational Medicine (2023) Vol. 15, Iss. 691
Open Access | Times Cited: 46
Stefan Naulaerts, Angeliki Datsi, Daniel Borràs, et al.
Science Translational Medicine (2023) Vol. 15, Iss. 691
Open Access | Times Cited: 46
Preexisting tumor-resident T cells with cytotoxic potential associate with response to neoadjuvant anti–PD-1 in head and neck cancer
Giacomo Oliveira, Ann Marie Egloff, Alexander B. Afeyan, et al.
Science Immunology (2023) Vol. 8, Iss. 87
Open Access | Times Cited: 44
Giacomo Oliveira, Ann Marie Egloff, Alexander B. Afeyan, et al.
Science Immunology (2023) Vol. 8, Iss. 87
Open Access | Times Cited: 44
Clinical and translational attributes of immune-related adverse events
Karijn P.M. Suijkerbuijk, Mick J M van Eijs, Femke van Wijk, et al.
Nature Cancer (2024) Vol. 5, Iss. 4, pp. 557-571
Closed Access | Times Cited: 36
Karijn P.M. Suijkerbuijk, Mick J M van Eijs, Femke van Wijk, et al.
Nature Cancer (2024) Vol. 5, Iss. 4, pp. 557-571
Closed Access | Times Cited: 36
CD4+ T cell activation distinguishes response to anti-PD-L1+anti-CTLA4 therapy from anti-PD-L1 monotherapy
Amelie Franken, Michel Bila, Aurelie Mechels, et al.
Immunity (2024) Vol. 57, Iss. 3, pp. 541-558.e7
Open Access | Times Cited: 33
Amelie Franken, Michel Bila, Aurelie Mechels, et al.
Immunity (2024) Vol. 57, Iss. 3, pp. 541-558.e7
Open Access | Times Cited: 33
The B7:CD28 family and friends: Unraveling coinhibitory interactions
Kelly P. Burke, Apoorvi Chaudhri, Gordon J. Freeman, et al.
Immunity (2024) Vol. 57, Iss. 2, pp. 223-244
Open Access | Times Cited: 32
Kelly P. Burke, Apoorvi Chaudhri, Gordon J. Freeman, et al.
Immunity (2024) Vol. 57, Iss. 2, pp. 223-244
Open Access | Times Cited: 32
Advances and prospects of biomarkers for immune checkpoint inhibitors
Hirohito Yamaguchi, Jung-Mao Hsu, Linlin Sun, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 7, pp. 101621-101621
Open Access | Times Cited: 30
Hirohito Yamaguchi, Jung-Mao Hsu, Linlin Sun, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 7, pp. 101621-101621
Open Access | Times Cited: 30
Using a pan-cancer atlas to investigate tumour associated macrophages as regulators of immunotherapy response
Alexander Coulton, Jun Murai, Danwen Qian, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 26
Alexander Coulton, Jun Murai, Danwen Qian, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 26
Immunotherapy and transplantation for hepatocellular carcinoma
Parissa Tabrizian, Maen Abdelrahim, Myron Schwartz
Journal of Hepatology (2024) Vol. 80, Iss. 5, pp. 822-825
Closed Access | Times Cited: 25
Parissa Tabrizian, Maen Abdelrahim, Myron Schwartz
Journal of Hepatology (2024) Vol. 80, Iss. 5, pp. 822-825
Closed Access | Times Cited: 25
The Multifaceted Role of Tissue-Resident Memory T Cells
Susan N. Christo, Simone L. Park, Scott N. Mueller, et al.
Annual Review of Immunology (2024) Vol. 42, Iss. 1, pp. 317-345
Closed Access | Times Cited: 22
Susan N. Christo, Simone L. Park, Scott N. Mueller, et al.
Annual Review of Immunology (2024) Vol. 42, Iss. 1, pp. 317-345
Closed Access | Times Cited: 22
Spatiotemporal single-cell analysis decodes cellular dynamics underlying different responses to immunotherapy in colorectal cancer
Yuqing Chen, Dongfang Wang, Yingjie Li, et al.
Cancer Cell (2024) Vol. 42, Iss. 7, pp. 1268-1285.e7
Open Access | Times Cited: 22
Yuqing Chen, Dongfang Wang, Yingjie Li, et al.
Cancer Cell (2024) Vol. 42, Iss. 7, pp. 1268-1285.e7
Open Access | Times Cited: 22
Chemotherapy‐Enabled Colorectal Cancer Immunotherapy of Self‐Delivery Nano‐PROTACs by Inhibiting Tumor Glycolysis and Avoiding Adaptive Immune Resistance
Linping Zhao, Rongrong Zheng, Xiaona Rao, et al.
Advanced Science (2024) Vol. 11, Iss. 15
Open Access | Times Cited: 21
Linping Zhao, Rongrong Zheng, Xiaona Rao, et al.
Advanced Science (2024) Vol. 11, Iss. 15
Open Access | Times Cited: 21
Spatial transcriptomics reveals that metabolic characteristics define the tumor immunosuppression microenvironment via iCAF transformation in oral squamous cell carcinoma
Zheqi Liu, Zhen Zhang, Yu Zhang, et al.
International Journal of Oral Science (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 19
Zheqi Liu, Zhen Zhang, Yu Zhang, et al.
International Journal of Oral Science (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 19
Spatial landscapes of cancers: insights and opportunities
Julia Chen, Ludvig Larsson, Alexander Swarbrick, et al.
Nature Reviews Clinical Oncology (2024) Vol. 21, Iss. 9, pp. 660-674
Closed Access | Times Cited: 18
Julia Chen, Ludvig Larsson, Alexander Swarbrick, et al.
Nature Reviews Clinical Oncology (2024) Vol. 21, Iss. 9, pp. 660-674
Closed Access | Times Cited: 18
Temporal and spatial composition of the tumor microenvironment predicts response to immune checkpoint inhibition
Noah F. Greenwald, Iris Nederlof, C. H. Sowers, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access | Times Cited: 2
Noah F. Greenwald, Iris Nederlof, C. H. Sowers, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access | Times Cited: 2
Contrasting cytotoxic and regulatory T cell responses underlying distinct clinical outcomes to anti-PD-1 plus lenvatinib therapy in cancer
Xinyi Guo, Hu Nie, Wenwen Zhang, et al.
Cancer Cell (2025)
Closed Access | Times Cited: 2
Xinyi Guo, Hu Nie, Wenwen Zhang, et al.
Cancer Cell (2025)
Closed Access | Times Cited: 2
